BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25652097)

  • 1. Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer.
    Liao MY; Kuo MY; Lu TY; Wang YP; Wu HC
    Int J Oncol; 2015 Apr; 46(4):1788-800. PubMed ID: 25652097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
    Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC
    Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between ganglioside expression and anti-cancer effects of the monoclonal antibody against epithelial cell adhesion molecule in colon cancer.
    Kwak DH; Ryu JS; Kim CH; Ko K; Ma JY; Hwang KA; Choo YK
    Exp Mol Med; 2011 Dec; 43(12):693-701. PubMed ID: 22033101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.
    Sankpal NV; Willman MW; Fleming TP; Mayfield JD; Gillanders WE
    Cancer Res; 2009 Feb; 69(3):753-7. PubMed ID: 19141643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
    Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant-derived EpCAM antigen induces protective anti-cancer response.
    Brodzik R; Spitsin S; Golovkin M; Bandurska K; Portocarrero C; Okulicz M; Steplewski Z; Koprowski H
    Cancer Immunol Immunother; 2008 Mar; 57(3):317-23. PubMed ID: 17634938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
    Kawashima R; Abei M; Fukuda K; Nakamura K; Murata T; Wakayama M; Seo E; Hasegawa N; Mizuguchi H; Obata Y; Hyodo I; Hamada H; Yokoyama KK
    Int J Cancer; 2011 Sep; 129(5):1244-53. PubMed ID: 21710497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
    Sterzynska K; Kempisty B; Zawierucha P; Zabel M
    Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma.
    Liljefors M; Nilsson B; Fagerberg J; Ragnhammar P; Mellstedt H; Frödin JE
    Int J Oncol; 2005 Jun; 26(6):1581-9. PubMed ID: 15870873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
    Takao M; Nagai Y; Torii T
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
    Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
    J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution studies of epithelial cell adhesion molecule (EpCAM)-directed monoclonal antibodies in the EpCAM-transgenic mouse tumor model.
    Kosterink JG; McLaughlin PM; Lub-de Hooge MN; Hendrikse HH; van Zanten J; van Garderen E; Harmsen MC; de Leij LF
    J Immunol; 2007 Jul; 179(2):1362-8. PubMed ID: 17617629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells.
    Lu TY; Lu RM; Liao MY; Yu J; Chung CH; Kao CF; Wu HC
    J Biol Chem; 2010 Mar; 285(12):8719-32. PubMed ID: 20064925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
    Martowicz A; Spizzo G; Gastl G; Untergasser G
    BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).
    El-Sahwi K; Bellone S; Cocco E; Casagrande F; Bellone M; Abu-Khalaf M; Buza N; Tavassoli FA; Hui P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Mol Cancer Ther; 2010 Jan; 9(1):57-66. PubMed ID: 20053761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.